|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Programmed cell death in cardiovascular biology and disease 显示文摘 | MacLellan WR Schneider MD | 1997 | Cir Res1997，81，1： | 1 |
| 2 | Tumor necrosis factor-α is persistently expressed in cardiac allografts in the absence of histological or clinical evidence of rejection显示文摘 | MacLellan WR Kapadia S | 1998 | Transplant Proc1998，30，： | 1 |
| 3 | Cardiac troponin I is associated with impaired hemodynamic, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure 显示文摘 | Horwich TB Patel J MacLellan WR | 2003 | Circulation2003，108，： | 1 |
| 4 | Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure显示文摘 | Horwich TB Hamilton MA Maclellan WR | 2002 | J Cardiol Fail2002，8，4： | 1 |
| 5 | Cardiac myocyte cell cycle control in development, disease, and regeneration 显示文摘 | Ahuja P Sdek P MacLellan WR | 2007 | Physiol Rev2007，87，2： | 1 |
| 6 | Cardiac myocyte cell cycle control in development, disease, and regeneration 显示文摘 | Ahuja P Sdek P MacLellan WR | 2007 | Physiol Rev2007，87，2： | 1 |
| 7 | Death by design program med cell death in cardiovascular biology and disease 显示文摘 | MacLellan WR Schneider MD | 1997 | Circ Res1997，81，2： | 1 |
| 8 | A dominant negative receptor for type beta transforming growth factors created by deletion of the kinase domain显示文摘 | Brand T MacLellan WR Schneider MD | 1993 | J Biol Chem1993，268，11： | 1 |
| 9 | Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure显示文摘 | HORWICH TB PATEL J MACLELLAN WR | 2003 | Circulation2003，108，7： | 1 |
| 10 | Atorvastatin and statins in the treatment of heart failure显示文摘 | Horwich TB MacLellan WR | 2007 | Export Opin Pharmacother2007，8，17： | 1 |
| 11 | Regulation of the mammalian cell cycle:a model of the G1-to-S transition显示文摘 | Qu Z Weiss JN MacLellan WR | 2003 | Am J Physiol Cell Physiol2003，284，2： | 1 |
| 12 | Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure显示文摘 | Horwich TB MacLellan WR Fonarow GC | 2004 | J Am Coll Cardiol2004，43，4： | 1 |
| 13 | Advances in the molecular mechanisms of heart failure显示文摘 | MacLellan WR | 2000 | Current Opin Cardiol2000，15，： | 1 |
| 14 | Death by design programmed cell death in cardiovascular biology and disease显示文摘 | Schneider MD | 1997 | CircRes1997，81，8： | 1 |
| 15 | Statin therapy is ass- ociated with improved survival in isehemic and non-ischermic heart failure显示文摘 | Horwicht B Maclellan WR Fonarow GC | 2004 | J Am Coil Cardiol2004，43，： | 1 |
| 16 | Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure显示文摘 | Horwich TB Maclellan WR Fonarow GC | | 0，，05： | 1 |
| 17 | Cardiac troponin I is associated with impaired hemodynamics,progressive left ventricular dysfunction,and inreased mortality rates in advanced heart failure显示文摘 | Horwich TB Patel J MacLellan WR | 2003 | Circulation2003，108，7： | 1 |
| 18 | Death by design:programmed cell death in cardiovascular biology and disease显示文摘 | Maclellan WR Michael D | 1997 | Cir Res1997，81，1： | 1 |
| 19 | Death by Design:Programmed cell death in cardiovascular biology and disease显示文摘 | Maclellan WR Schneider MD | 1997 | Circ Res1997，81，： | 1 |
| 20 | Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor显示文摘 | Sivasubramanian N Coker ML Kurrelmeyer KM MacLellan WR DeMayo FJ Spinale FG Mann DL | 2001 | Circulation2001，104，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员